It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks:

Biocryst Pharmaceuticals: "I'm not going to go with that one, because that's been knocking around for a long time with enzyme specialty pharma. It doesn't have what I want, which are these big phase three drugs that are about to go on the market."

Duke Energy Corp: "All the utilities have been slammed here over the false fears that the Fed is going to instantly start raising rates. I'm going to say that I like Duke, but I see you and raise you with Dominion."

Northwest Biotherapeutics: "That is a very controversial stock and it's really in the cross hairs of a lot of longs and shorts. I've got to do more work on it before I opine on it because that is one of those that is a week-to-week. I can't cuff it."

Sonic Corporation: "Oh man I really like Sonic. I think it's just terrific and it's got the best growth profiles of all the fast foods out there."

----------------------------------------------------------
Read more from Mad Money with Jim Cramer
Cramer Remix: Oil news you've waited on
Starbucks CEO speaks out on race
Cramer: $$ rolling into this sector—thanks to Fed
----------------------------------------------------------

Invensense Inc: "It's the innards of different products, and if you want innards I'm always going to come back with Skyworks Solutions even though it hit a 52-week high today."

Chicago Bridge & Iron: "Great guys, just terrific. But at the same time they do a lot of energy infrastructure work. Energy infrastructure is not a good business to be levered to with oil at the $42-$43 level,"

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com